• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人免疫缺陷病毒感染患者中与乌普萨拉弯曲菌相关的腹泻

Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients.

作者信息

Jenkin G A, Tee W

机构信息

Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia.

出版信息

Clin Infect Dis. 1998 Oct;27(4):816-21. doi: 10.1086/514957.

DOI:10.1086/514957
PMID:9798039
Abstract

Campylobacter upsaliensis was isolated from the feces of 20 human immunodeficiency virus (HIV)-infected patients with diarrhea over a 67-month period, representing 18.5% of fecal Campylobacter isolates from our HIV-seropositive patients. All isolates were recovered from feces by a 0.45-micron-membrane filtration method. Culture on Skirrow's selective medium incubated at 42 degrees C failed to support any growth. The mean CD4 cell count of the patient group was 185/mm3 (range, 0-840/mm3), and all patients had diarrhea for 1-60 days (mean, 19 days). Thirteen had no other enteric pathogen isolated, and three patients (CD4 counts, < or = 70/mm3) had persistent carriage for between 5 weeks and 3 months. All tested isolates were susceptible to erythromycin and doxycycline, but three isolates from two patients were resistant to ciprofloxacin. C. upsaliensis is associated with prolonged diarrhea of mild to moderate severity in HIV-infected patients.

摘要

在67个月的时间里,从20例腹泻的人类免疫缺陷病毒(HIV)感染患者的粪便中分离出了乌普萨拉弯曲菌,占我们HIV血清阳性患者粪便弯曲菌分离株的18.5%。所有分离株均通过0.45微米膜过滤法从粪便中回收。在42℃孵育的斯金罗(Skirrow)选择性培养基上培养未能支持任何生长。患者组的平均CD4细胞计数为185/mm³(范围为0 - 840/mm³),所有患者腹泻1 - 60天(平均19天)。13例未分离出其他肠道病原体,3例患者(CD4计数≤70/mm³)持续携带该菌5周至3个月。所有检测的分离株对红霉素和强力霉素敏感,但来自两名患者的3株分离株对环丙沙星耐药。乌普萨拉弯曲菌与HIV感染患者轻度至中度严重程度的长期腹泻有关。

相似文献

1
Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients.人免疫缺陷病毒感染患者中与乌普萨拉弯曲菌相关的腹泻
Clin Infect Dis. 1998 Oct;27(4):816-21. doi: 10.1086/514957.
2
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus.感染人类免疫缺陷病毒的患者中弯曲杆菌相关性腹泻的患病率。
Clin Infect Dis. 1997 Jun;24(6):1107-13. doi: 10.1086/513643.
3
Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru.秘鲁利马一项关于成人HIV-1感染患者持续性腹泻病因及表现的病例对照研究
J Infect Dis. 2005 Jan 1;191(1):11-9. doi: 10.1086/426508. Epub 2004 Dec 1.
4
Use of ciprofloxacin for successful eradication of bacteremia due to Campylobacter cinaedi in a human immunodeficiency virus-infected person.环丙沙星用于成功根除一名感染人类免疫缺陷病毒者的西奈弯曲菌菌血症。
Rev Infect Dis. 1991 Nov-Dec;13(6):1066-8. doi: 10.1093/clinids/13.6.1066.
5
Characterization and description of "Campylobacter upsaliensis" isolated from human feces.从人类粪便中分离出的“乌普萨拉弯曲菌”的鉴定与描述。
J Clin Microbiol. 1990 May;28(5):1039-46. doi: 10.1128/jcm.28.5.1039-1046.1990.
6
Frequency of occurrence and characterization of catalase negative Campylobacter isolated from human feces in Vienna.从维也纳人类粪便中分离出的过氧化氢酶阴性弯曲杆菌的发生率及特征
Zentralbl Bakteriol. 1990 Apr;272(4):547-53. doi: 10.1016/s0934-8840(11)80057-5.
7
Detection of Campylobacter upsaliensis in diarrheic dogs and cats, using a selective medium with cefoperazone.使用含头孢哌酮的选择性培养基检测腹泻犬猫中的乌普萨拉弯曲菌。
Am J Vet Res. 1992 Jan;53(1):48-51.
8
Isolation of group 2 aerotolerant Campylobacter species from Thai children with diarrhea.从泰国腹泻儿童中分离出2型耐氧弯曲菌属菌种。
J Infect Dis. 1991 May;163(5):1062-7. doi: 10.1093/infdis/163.5.1062.
9
Is "Campylobacter upsaliensis" an unrecognised cause of human diarrhoea?
Lancet. 1990 Mar 10;335(8689):584-6. doi: 10.1016/0140-6736(90)90359-d.
10
Campylobacter-like organisms are uncommon pathogens in patients infected with the human immunodeficiency virus.类弯曲杆菌是感染人类免疫缺陷病毒患者中不常见的病原体。
J Clin Microbiol. 1990 Oct;28(10):2370-1. doi: 10.1128/jcm.28.10.2370-2371.1990.

引用本文的文献

1
Evaluation of a rapid fluorescence immunoassay for detecting Campylobacter antigens in stool samples.用于检测粪便样本中弯曲杆菌抗原的快速荧光免疫测定法的评估。
Gut Pathog. 2025 Feb 28;17(1):12. doi: 10.1186/s13099-025-00686-4.
2
A scoping review of factors associated with antimicrobial-resistant species infections in humans.抗微生物药物耐药物种感染相关因素的范围综述。
Epidemiol Infect. 2023 Jun 7;151:e100. doi: 10.1017/S0950268823000742.
3
A systematic review and meta-analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan Africa.
系统评价和荟萃分析显示,弯曲杆菌属和抗生素耐药性在撒哈拉以南非洲的人类中广泛存在。
PLoS One. 2021 Jan 27;16(1):e0245951. doi: 10.1371/journal.pone.0245951. eCollection 2021.
4
Pathogenomics of Emerging Species.新兴物种的病原体组学。
Clin Microbiol Rev. 2019 Jul 3;32(4). doi: 10.1128/CMR.00072-18. Print 2019 Sep 18.
5
Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.BioFire FilmArray胃肠道检测板用于感染性肠胃炎病因诊断的多中心评估
J Clin Microbiol. 2015 Mar;53(3):915-25. doi: 10.1128/JCM.02674-14. Epub 2015 Jan 14.
6
First case report of fatal sepsis due to Campylobacter upsaliensis.首例因乌普萨拉弯曲杆菌导致的致命性败血症病例报告。
J Clin Microbiol. 2015 Feb;53(2):713-5. doi: 10.1128/JCM.02349-14. Epub 2014 Nov 19.
7
Association of Campylobacter upsaliensis with persistent bloody diarrhea.乌斯怀亚弯曲杆菌与持续性血性腹泻的关联性。
J Clin Microbiol. 2012 Nov;50(11):3792-4. doi: 10.1128/JCM.01807-12. Epub 2012 Aug 22.
8
The clinical importance of emerging Campylobacter species.新兴弯曲杆菌种的临床重要性。
Nat Rev Gastroenterol Hepatol. 2011 Oct 25;8(12):669-85. doi: 10.1038/nrgastro.2011.191.
9
Multiple zoonotic pathogens identified in canine feces collected from a remote Canadian indigenous community.从加拿大偏远原住民社区采集的犬粪便中鉴定出多种人畜共患病原体。
Am J Trop Med Hyg. 2010 Aug;83(2):338-41. doi: 10.4269/ajtmh.2010.10-0137.
10
High-resolution genotyping of Campylobacter upsaliensis strains originating from three continents.对源自三大洲的乌普萨拉弯曲杆菌菌株进行高分辨率基因分型。
J Clin Microbiol. 2004 Aug;42(8):3441-8. doi: 10.1128/JCM.42.8.3441-3448.2004.